BLC
AVNS

Brown, Lisle/Cummings’s Avanos Medical AVNS Stock Holding History

Brown, Lisle/Cummings’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-11
Closed -$264 – 641
2024
Q3 		$264 Hold
11
– – ﹤0.01% 611
2024
Q2 		$219 Hold
11
– – ﹤0.01% 605
2024
Q1 		$219 Hold
11
– – ﹤0.01% 552
2023
Q4 		$247 Hold
11
– – ﹤0.01% 565
2023
Q3 		$222 Hold
11
– – ﹤0.01% 545
2023
Q2 		$281 Hold
11
– – ﹤0.01% 548
2023
Q1 		$327 Hold
11
– – ﹤0.01% 525
2022
Q4 		$298 Hold
11
– – ﹤0.01% 513
2022
Q3 		$240 Hold
11
– – ﹤0.01% 506
2022
Q2 		$301 Hold
11
– – ﹤0.01% 470
2022
Q1 		$369 Hold
11
– – ﹤0.01% 474
2021
Q4 		$381 Buy
+11
New +$356 ﹤0.01% 449

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

Brown, Lisle/Cummings's AVNS Position: Q4 2024 in Review

Brown, Lisle/Cummings sold out of Avanos Medical (AVNS) in Q4 2024, closing a stake of 11 shares — an estimated $264 sold.

Brown, Lisle/Cummings first reported a position in AVNS in Q4 2021 and held it in 12 quarters. The position peaked at $381 in Q4 2021. 258 funds tracked by Wall St. Rank hold AVNS as of Q4 2024.

  • Brown, Lisle/Cummings reported no remaining Avanos Medical position as of Q4 2024 after selling out during the quarter.
  • Brown, Lisle/Cummings sold 11 Avanos Medical shares in Q4 2024, an estimated $264.
  • Brown, Lisle/Cummings first reported a position in Avanos Medical in Q4 2021 and held it in 12 quarters.
  • Brown, Lisle/Cummings's Avanos Medical position peaked at $381 in Q4 2021.
  • 258 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2024.

Based on Brown, Lisle/Cummings's 13F filing for Q4 2024, filed 27 Jan 2025.